DIA Biosimilars 2013

BioNano Genomics

BioNano Genomics launches Irys for complex human genome analysis

Wednesday, November 7, 2012 09:47 AM

BioNano Genomics, a San Diego-based genomics company, has launched its Irys System, an intuitively designed genome mapping system that empowers genomics researchers with a new way of analyzing genomic DNA.

More... »

Cenduit: Now with Patient Reminders

BioNano names Monroe CFO

Monday, December 5, 2011 02:57 PM

BioNano Genomics has named Garth Monroe chief financial officer. Monroe will report to president and chief executive officer Dr. R. Erik Holmlin.

More... »

CRF Health – eCOA Forum

BioNanomatrix changes name to BioNano Genomics

Tuesday, October 11, 2011 12:48 PM

BioNanomatrix has changed its name to BioNano Genomics.  By adopting the new name, the company is communicating its position as a solution provider for genomics researchers who want to fully understand the biology of the genomes at the core of their research.  The change follows the recent establishment of new corporate headquarters in San Diego, the appointment of new leadership, and additional new investment.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs